Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +28.33%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +25.08%
#7 Enso Enso +18.12%
#8 Velvet Velvet +16.00%
#9 Tutorial Tutorial +15.35%
#10 OVERTAKE OVERTAKE +15.31%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rang în acțiuni #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Preț acțiune
$0.07600875
Ultima sincronizare: 2024-11-20
Capitalizare de piață
$2.06M
Schimbare (1 zi)
-0.51%
Schimbare (1 an)
0.00%
Țară
FR
Tranzacționează Quantum Genomics S.A. (ALQGC)

Categorie

Healthcare
Venituri pentru Quantum Genomics S.A. (ALQGC)
Venituri în Dec 2024 TTM: $2.14K
Conform celor mai recente rapoarte financiare ale Quantum Genomics S.A., venitul actual al companiei (TTM) este $2.14K. În anul 2023, compania a avut un venit de $21.88K o scădere comparativ cu venitul din anul 2022, care a fost de $2.70M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Quantum Genomics S.A. din 2009 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $2.14K 20,481.43%
2024 $10.41 -99.95%
2023 $21.88K -99.19%
2022 $2.70M -24.40%
2021 $3.57M 60.20%
2020 $2.23M 28.33%
2019 $1.74M 40,877.53%
2018 $4.24K 0.00%
2017 0.00 0.00%
2016 0.00 -100.00%
2015 $156.51K -60.11%
2014 $392.39K 1,539.89%
2013 $23.93K -5.52%
2012 $25.33K 1.90%
2011 $24.85K -3.18%
2010 $25.67K -6.76%
2009 $27.53K 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 589,224,844.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 281,036,684.84%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 471,909,450.14%
BE